RACHAEL COTTRILL: Open Payments
NPI 1609488592 · PORTSMOUTH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$680 in 36 payments from 9 companies in 2025. Trend: 2023 $1,350 · 2024 $426 · 2025 $680
Food & beverage: $680
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $369 |
| Axsome Therapeutics, Inc. | 3 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| Alkermes, Inc. | 2 | $55 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: VRAYLAR, Auvelity, REXULTI, LYBALVI, CAPLYTA, ARISTADA, AUSTEDO XR, INGREZZA.
Industry payments across OH — which companies pay providers there.
